Fatty liver breakthrough? protein levels may predict best diabetes drug
NCT ID NCT07539584
First seen Apr 21, 2026 · Last updated May 14, 2026 · Updated 7 times
Summary
This study looked at 130 adults with type 2 diabetes and fatty liver disease to see if a protein called adiponectin can help predict which diabetes drugs work best. Participants received one of three treatments or no drug therapy for six months. The goal was to understand how adiponectin levels change and whether they relate to improvements in liver fat.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Moscow Regional Research and Clinical Institute
Moscow, 129110, Russia
Conditions
Explore the condition pages connected to this study.